Edition:
United Kingdom

MYnd Analytics Inc (MYND.OQ)

MYND.OQ on NASDAQ Stock Exchange Capital Market

3.32USD
18 May 2018
Change (% chg)

$0.12 (+3.75%)
Prev Close
$3.20
Open
$3.32
Day's High
$3.65
Day's Low
$3.25
Volume
34,578
Avg. Vol
31,652
52-wk High
$5.24
52-wk Low
$1.15

Chart for

About

MYnd Analytics, Inc., formerly CNS Response, Inc., is a predictive analytics company. The Company has developed a decision support tool to help physicians reduce trial and error treatment in mental health, and provide personalized care to patients. The Company provides objective clinical decision support to mental healthcare... (more)

Overall

Beta: 0.55
Market Cap(Mil.): $16.24
Shares Outstanding(Mil.): 4.24
Dividend: --
Yield (%): --

Financials

  MYND.OQ Industry Sector
P/E (TTM): -- 28.41 32.75
EPS (TTM): -2.90 -- --
ROI: -- 6.42 14.38
ROE: -- 10.07 16.07

BRIEF-MYnd Completes Private Placement By Company Insiders At Significant Premium To Market 

* MYND COMPLETES $2.1 MILLION DOLLAR PRIVATE PLACEMENT BY COMPANY INSIDERS AT SIGNIFICANT PREMIUM TO MARKET Source text for Eikon: Further company coverage:

03 Apr 2018

BRIEF-Mynd Analytics Inc Files For Stock Shelf Of Upto $75 Million

* MYND ANALYTICS INC FILES FOR STOCK SHELF OF UPTO $75 MILLION Source text: (http://bit.ly/2BOol6H) Further company coverage:

23 Feb 2018

BRIEF-MYnd Analytics Awarded Canadian Patent On Neuromodulation Platform Predicts Patients Likely To Respond To TMS For Treating Depression

* MYND ANALYTICS AWARDED CANADIAN PATENT ON NEUROMODULATION PLATFORM; PREDICTS PATIENTS LIKELY TO RESPOND TO TMS FOR TREATING DEPRESSION Source text for Eikon: Further company coverage:

08 Feb 2018

Earnings vs. Estimates